Boston Scientific (NYSE:BSX – Get Rating) had its target price hoisted by Mizuho from $52.00 to $56.00 in a research note issued to investors on Tuesday morning, The Fly reports. A number of other brokerages have also commented on BSX. Truist Financial boosted their price target on Boston Scientific from $54.00 to $59.00 and gave […]
ProShare Advisors LLC lessened its stake in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 2.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 193,939 shares of the medical equipment provider’s stock after selling 5,469 shares during […]
Great Waters Wealth Management purchased a new position in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,794 shares of the medical equipment provider’s stock, valued at approximately $498,000. A number of […]
Boston Scientific (NYSE:BSX – Get Rating) had its target price upped by Raymond James from $56.00 to $60.00 in a research report sent to investors on Monday, The Fly reports. The brokerage currently has a strong-buy rating on the medical equipment provider’s stock. BSX has been the topic of a number of other research reports. […]
Nisa Investment Advisors LLC lessened its stake in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 2.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 322,066 shares of the medical equipment provider’s stock after selling 9,160 shares […]